30/10/2024
resurges as
The World Health Organization today published a new report on tuberculosis revealing that approximately 8.2 million people were newly diagnosed with TB in 2023 – the highest number recorded since WHO began global TB monitoring in 1995. This represents a notable increase from 7.5 million reported in 2022, placing TB again as the leading infectious disease killer in 2023, surpassing
WHO’s Global Tuberculosis Report 2024 highlights mixed progress in the global fight against TB, with persistent challenges such as significant underfunding. While the number of TB-related decreased from 1.32 million in 2022 to 1.25 million in 2023, the total number of people falling ill with TB rose slightly to an estimated 10.8 million in 2023
With the disease disproportionately affecting people in 30 high-burden countries, (26%), (10%), (6.8%), the (6.8%) and (6.3%) together accounted for 56% of the global TB burden. According to the report, 55% of people who developed TB were , 33% were and 12% were and young
“The fact that TB still kills and sickens so many people is an outrage, when we have the tools to prevent it, detect it and treat it,” said Tedros Adhanom Ghebreyesus, WHO DG. “WHO urges all countries to make good on the concrete commitments they have made to expand the use of those tools, and to end TB.”
In 2023, the gap between the estimated number of new TB cases and those reported narrowed to about 2.7 M, down from COVID-19 pandemic levels of around 4 M in 2020 and 2021. This follows substantial national and global efforts to recover from COVID-related disruptions to TB services. The coverage of TB has been sustained for people living with HIV and continues to improve for household contacts of people diagnosed with TB
However, multidrug-resistant TB remains a . Treatment success rates for multidrug-resistant or rifampicin-resistant TB have now reached 68%. But, of the 400 000 people estimated to have developed MDR/RR-TB, only 44% were diagnosed and treated in 2023
Global funding for TB prevention and care decreased further in 2023 and remains far below target. LMICs, which bear 98% of the TB burden, faced significant funding shortages. Only US$ 5.7 billion of the US$ 22 billion annual funding target was available in 2023, equivalent to only 26% of the global target
The total amount of international donor funding in LMICs has remained at around US$ 1.1–1.2 billion per year for several years. The US Government remains the largest bilateral donor for TB. While The Global Fund contribution to international funding of the TB response, especially in LMICs, is important, it remains insufficient to cover essential TB service needs.
The World Health Organization (WHO) today published a new report on tuberculosis revealing that approximately 8.2 million people were newly diagnosed with TB in 2023 – the highest number recorded since WHO began global TB monitoring in 1995.
